Cancer News and Stories
Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Filtering by:
Cancer UpdatesStudy Finds Possible Link Between Hair Straightening Chemicals and Uterine Cancer
Published on: October 26, 2022
Women who use chemical hair straighteners and relaxers may have a higher risk of uterine cancer, according to a new study from researchers at the US National Institutes of Health (NIH).
Impact Ratings Show Cancer Journal Continues to Outperform
Published on: July 2, 2021
The annual scientific and clinical Journal Impact Factors were released on June 30, and the American Cancer Society’s CA: A Cancer Journal for Clinicians outperformed. The CA impact factor climbed from 292.3 last year to a staggering 508.7 and remains the highest-rated oncology journal in the world.
Cervical Precancers Drop Since Introduction of HPV Vaccine
Published on: December 9, 2020
A study using data from the Centers for Disease Control and Prevention (CDC) provides evidence that the human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical precancer – lesions that can become cervical cancer.
FDA Approves First Drug for Cancers with a High Tumor Mutational Burden
Published on: June 18, 2020
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug pembrolizumab (Keytruda) to include any cancer with a high tumor mutational burden (TMB-H).
American Cancer Society Updates Guideline for Diet and Physical Activity
Published on: June 9, 2020
The American Cancer Society has updated its guideline on diet and physical activity for cancer prevention. Staying at a healthy weight, staying active throughout life, following a healthy eating pattern, and avoiding or limiting alcohol may greatly reduce a person's lifetime risk of developing or dying from cancer.
FDA Approves Trodelvy (Sacituzumab govitecan-hziy) for Triple Negative Breast Cancer
Published on: April 29, 2020
The US Food and Drug Administration (FDA) approved a new type of therapy for triple-negative breast cancer that has spread to other parts of the body and hasn’t responded to other treatments.
FDA Approves Pemazyre (Pemigatinib) for Bile Duct Cancer
Published on: April 22, 2020
The US Food and Drug Administration (FDA) approved the first targeted therapy for bile duct cancer. Pemazyre (pemigatinib) is for adults whose cancer has grown after at least one previous chemotherapy treatment and whose tumors have a mutation in the FGFR2 gene.
FDA Approves Jelmyto (Mitomycin gel) for Urothelial Cancer
Published on: April 20, 2020
The US Food and Drug Administration (FDA) approved Jelmyto (mitomycin gel) for a type of urothelial cancer, which is a cancer of the lining of the urinary system.